Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 11.7 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
56 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
68.3% now, 75.0% in Sep 2025 · highest 82.4%, lowest 67.9%
Companies held
27 now, 24 in Sep 2025 · largest single holding 9.7% of equity
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- NIPPON INDIA PHARMA FUNDNippon India · 15 shared45.2%
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 16 shared44.2%
- ICICI Prudential Healthcare FundICICI Prudential · 16 shared42.5%
- UTI - Healthcare FundUTI · 18 shared42.3%
- ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Prudential · 14 shared40.8%
- HDFC Pharma and Healthcare FundHDFC · 14 shared37.9%
- Bandhan Healthcare FundBandhan · 11 shared37.8%
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 15 shared36.9%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| IPCA Laboratories Limited | Healthcare | Mid Cap | 9.69% | 305 Cr | 0.16 Cr | by Jan 2022 (56 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 8.86% | 279 Cr | 0.15 Cr | by Jan 2022 (56 mo+) |
| Cipla Limited | Healthcare | Large Cap | 8.56% | 269 Cr | 0.20 Cr | by Jan 2022 (56 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 7.76% | 244 Cr | 0.16 Cr | Dec 2024 (22 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 7.32% | 231 Cr | 0.08 Cr | Jun 2024 (28 mo) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.23% | 228 Cr | 0.03 Cr | by Jan 2022 (56 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 5.65% | 178 Cr | 0.03 Cr | by Jan 2022 (56 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 4.96% | 156 Cr | 0.02 Cr | Jul 2026 (3 mo) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 4.52% | 142 Cr | 0.32 Cr | Oct 2022 (47 mo) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 3.78% | 119 Cr | 0.14 Cr | by Jan 2022 (56 mo+) |
| Kovai Medical Center & Hospital Limited | Not classified | Small Cap | 3.37% | 106 Cr | 0.02 Cr | by Jan 2022 (56 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 3.24% | 102 Cr | 0.03 Cr | Oct 2022 (47 mo) |
| Concord Biotech Limited | Healthcare | Small Cap | 3.21% | 101 Cr | 0.07 Cr | Aug 2023 (37 mo) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 2.81% | 88.61 Cr | 0.02 Cr | by Jan 2022 (56 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 2.81% | 88.52 Cr | 0.06 Cr | by Jan 2022 (56 mo+) |
| Indoco Remedies Limited | Not classified | Small Cap | 2.70% | 84.93 Cr | 0.32 Cr | by Jan 2022 (56 mo+) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 2.28% | 71.64 Cr | 0.13 Cr | Aug 2026 (2 mo) |
| Manipal Health Enterprises Limited | Not classified | — | 2.20% | 69.42 Cr | 0.10 Cr | Jul 2026 (3 mo) |
| Unichem Laboratories Limited | Not classified | Small Cap | 1.96% | 61.57 Cr | 0.11 Cr | Jun 2023 (39 mo) |
| Syngene International Limited | Healthcare | Small Cap | 1.61% | 50.60 Cr | 0.14 Cr | Jun 2026 (4 mo) |
| Nephrocare Health Services Limited | Healthcare | Small Cap | 1.33% | 41.89 Cr | 0.06 Cr | Dec 2025 (10 mo) |
| ICICI Lombard General Insurance Company Limited | Financial Services | Mid Cap | 1.22% | 38.38 Cr | 0.02 Cr | by Jan 2022 (56 mo+) |
| Aarti Drugs Limited | Not classified | Small Cap | 1.17% | 36.72 Cr | 0.09 Cr | by Jan 2022 (56 mo+) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 0.86% | 26.92 Cr | 0.02 Cr | Jul 2026 (3 mo) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 0.42% | 13.10 Cr | 0.05 Cr | Sep 2023 (36 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 0.32% | 9.92 Cr | 3,658 | Sep 2026 (1 mo) |
| Laxmi Dental Limited | Not classified | Small Cap | 0.17% | 5.37 Cr | 0.03 Cr | Jan 2025 (21 mo) |
Half of its current holdings have been held for 47 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Manipal Health Enterprises Limited | Sep 2026 | ▼ Reducing | -0.09 Cr |
| Sai Life Sciences Limited | Sep 2026 | ▼ Reducing | -0.04 Cr |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +50,793 |
| Abbott India Limited | Sep 2026 | ▲ New position | +3,658 |
| Thyrocare Technologies Limited | Aug 2026 | ▲ New position | +0.13 Cr |
| Vijaya Diagnostic Centre Limited | Aug 2026 | ▼ Reducing | -0.03 Cr |
| Concord Biotech Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Gland Pharma Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +62,975 |
| Pfizer Limited | Aug 2026 | ▲ Increasing | +57,949 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +43,297 |
| Kovai Medical Center & Hospital Limited | Aug 2026 | ▲ Increasing | +8,810 |
| Unichem Laboratories Limited | Aug 2026 | ▲ Increasing | +4,171 |
| Manipal Health Enterprises Limited | Jul 2026 | ▲ New position | +0.19 Cr |
| Eris Lifesciences Limited | Jul 2026 | ▲ New position | +0.02 Cr |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Alkem Laboratories Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Divi's Laboratories Limited | Jul 2026 | ▲ New position | +0.01 Cr |
| Emcure Pharmaceuticals Limited | Jul 2026 | ▼ Complete exit | -69,966 |
| Jupiter Life Line Hospitals Limited | Jul 2026 | ▲ Increasing | +45,950 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▲ Increasing | +40,665 |
| Cohance Lifesciences Limited | Jul 2026 | ▲ Increasing | +23,118 |
| Unichem Laboratories Limited | Jul 2026 | ▲ Increasing | +13,881 |
| Pfizer Limited | Jul 2026 | ▲ Increasing | +5,034 |
| Syngene International Limited | Jun 2026 | ▲ New position | +0.11 Cr |
| Laurus Labs Limited | Jun 2026 | ▼ Complete exit | -0.09 Cr |
| Unichem Laboratories Limited | Jun 2026 | ▲ Increasing | +0.03 Cr |
| Emcure Pharmaceuticals Limited | Jun 2026 | ▼ Reducing | -0.02 Cr |
| Cipla Limited | Jun 2026 | ▲ Increasing | +0.02 Cr |
| Alkem Laboratories Limited | Jun 2026 | ▲ Increasing | +0.01 Cr |
| Kovai Medical Center & Hospital Limited | Jun 2026 | ▲ Increasing | +2,849 |
| Laurus Labs Limited | May 2026 | ▼ Reducing | -0.09 Cr |
| Medplus Health Services Limited | May 2026 | ▼ Complete exit | -0.02 Cr |
| Sai Life Sciences Limited | May 2026 | ▲ Increasing | +0.02 Cr |
| Emcure Pharmaceuticals Limited | May 2026 | ▼ Reducing | -82,806 |
| Cohance Lifesciences Limited | May 2026 | ▲ Increasing | +39,251 |
| CORONA Remedies Limited | May 2026 | ▼ Complete exit | -27,314 |
| Alembic Pharmaceuticals Limited | May 2026 | ▲ Increasing | +14,336 |
| Indoco Remedies Limited | May 2026 | ▲ Increasing | +12,208 |
| Unichem Laboratories Limited | May 2026 | ▲ Increasing | +3,048 |
| Cohance Lifesciences Limited | Apr 2026 | ▲ Increasing | +0.02 Cr |
| CORONA Remedies Limited | Apr 2026 | ▼ Reducing | -89,656 |
| Emcure Pharmaceuticals Limited | Apr 2026 | ▼ Reducing | -11,389 |
| Concord Biotech Limited | Feb 2026 | ▲ Increasing | +6,914 |
| Thyrocare Technologies Limited | Jan 2026 | ▼ Complete exit | -42,573 |
| Cipla Limited | Jan 2026 | ▲ Increasing | +22,981 |
| Cohance Lifesciences Limited | Jan 2026 | ▲ Increasing | +4,613 |
| Nephrocare Health Services Limited | Dec 2025 | ▲ New position | +0.06 Cr |
| CORONA Remedies Limited | Dec 2025 | ▲ New position | +0.01 Cr |
| Laurus Labs Limited | Dec 2025 | ▼ Reducing | -81,858 |
| Thyrocare Technologies Limited | Dec 2025 | ▼ Reducing | -36,155 |
| Thyrocare Technologies Limited | Nov 2025 | ▼ Reducing | -0.05 Cr |
| Laurus Labs Limited | Nov 2025 | ▼ Reducing | -0.03 Cr |
| Emcure Pharmaceuticals Limited | Nov 2025 | ▼ Reducing | -5,202 |
| Cohance Lifesciences Limited | Oct 2025 | ▲ Increasing | +0.02 Cr |
| Sai Life Sciences Limited | Oct 2025 | ▲ Increasing | +89,231 |
| Cohance Lifesciences Limited | Sep 2025 | ▲ Increasing | +0.02 Cr |
| Cohance Lifesciences Limited | Aug 2025 | ▲ Increasing | +0.01 Cr |
| Thyrocare Technologies Limited | Aug 2025 | ▼ Reducing | -45,395 |
| Emcure Pharmaceuticals Limited | Jul 2025 | ▲ Increasing | +50,513 |
| Narayana Hrudayalaya Ltd. | Jun 2025 | ▼ Complete exit | -0.01 Cr |
| Sai Life Sciences Limited | Jun 2025 | ▲ Increasing | +0.01 Cr |
| Procter & Gamble Health Limited | Jun 2025 | ▲ Increasing | +584 |
| Narayana Hrudayalaya Ltd. | May 2025 | ▼ Reducing | -0.01 Cr |
| Sun Pharmaceutical Industries Limited | Apr 2025 | ▼ Reducing | -0.03 Cr |
| IPCA Laboratories Limited | Apr 2025 | ▲ Increasing | +92,396 |
| Vijaya Diagnostic Centre Limited | Apr 2025 | ▼ Reducing | -83,542 |
| Narayana Hrudayalaya Ltd. | Apr 2025 | ▼ Reducing | -72,739 |
| Unichem Laboratories Limited | Apr 2025 | ▲ Increasing | +8,205 |
| Alembic Pharmaceuticals Limited | Apr 2025 | ▲ Increasing | +4,617 |
| Jupiter Life Line Hospitals Limited | Apr 2025 | ▼ Reducing | -2,361 |
| Lupin Limited | Mar 2025 | ▼ Complete exit | -80,146 |
| Unichem Laboratories Limited | Feb 2025 | ▲ Increasing | +0.01 Cr |
| Concord Biotech Limited | Feb 2025 | ▼ Reducing | -94,192 |
| Laurus Labs Limited | Feb 2025 | ▼ Reducing | -37,473 |
| Aarti Drugs Limited | Feb 2025 | ▲ Increasing | +13,347 |
| Pfizer Limited | Feb 2025 | ▲ Increasing | +1,802 |
| Laurus Labs Limited | Jan 2025 | ▲ Increasing | +0.03 Cr |
| Laxmi Dental Limited | Jan 2025 | ▲ New position | +0.03 Cr |
| Thyrocare Technologies Limited | Jan 2025 | ▲ Increasing | +0.02 Cr |
| Gland Pharma Limited | Jan 2025 | ▲ Increasing | +98,132 |
| Indoco Remedies Limited | Jan 2025 | ▲ Increasing | +47,343 |
| Aarti Drugs Limited | Jan 2025 | ▲ Increasing | +30,541 |
| Pfizer Limited | Jan 2025 | ▲ Increasing | +21,002 |
| Sai Life Sciences Limited | Jan 2025 | ▲ Increasing | +18,186 |
| Apollo Hospitals Enterprise Limited | Jan 2025 | ▲ Increasing | +8,561 |
| Sai Life Sciences Limited | Dec 2024 | ▲ New position | +0.16 Cr |
| Cipla Limited | Dec 2024 | ▲ Increasing | +0.01 Cr |
| Aarti Drugs Limited | Dec 2024 | ▲ Increasing | +75,574 |
| Pfizer Limited | Dec 2024 | ▲ Increasing | +33,703 |
| Indoco Remedies Limited | Nov 2024 | ▲ Increasing | +0.07 Cr |
| Laurus Labs Limited | Nov 2024 | ▲ Increasing | +0.05 Cr |
| Lupin Limited | Nov 2024 | ▼ Reducing | -0.05 Cr |
| Cipla Limited | Nov 2024 | ▲ Increasing | +0.03 Cr |
| Cohance Lifesciences Limited | Nov 2024 | ▼ Reducing | -96,395 |
| Narayana Hrudayalaya Ltd. | Nov 2024 | ▲ Increasing | +23,366 |
| Laurus Labs Limited | Oct 2024 | ▲ New position | +0.14 Cr |
| Lupin Limited | Oct 2024 | ▼ Reducing | -0.05 Cr |
Changes compare consecutive month-end disclosures for this portfolio only.